We’ve developed a platform that uncovers the activation status of therapeutically actionable genes and pathways from a simple blood test. We partner with developers of new medicines and advance our own diagnostic tests. We’re working towards a world where new medicine development efforts succeed more frequently, and where anyone can receive a minimally invasive diagnosis and treatment that’s precise to the biology of their disease.